1 / 42

CHRONIC KIDNEY DISEASE (CKD)

CHRONIC KIDNEY DISEASE (CKD). ETIOLOGY PATHOPHYSIOLOGY CLINIC. Background. CKD is a worldwide public health problem There is a rising incidence and prevalence of kidney failure with poor outcomes and high costs Adverse outcomes of CKD can be prevented or delayed

kerem
Télécharger la présentation

CHRONIC KIDNEY DISEASE (CKD)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CHRONIC KIDNEY DISEASE (CKD) ETIOLOGY PATHOPHYSIOLOGY CLINIC

  2. Background • CKD is a worldwide public health problem • There is a rising incidence and prevalence of kidney failure with poor outcomes and high costs • Adverse outcomes of CKD can be prevented or delayed • Earlier stages od CKD can be detected through lab testing

  3. CKD is often under-diagnosed and under-treated resulting in lost opportunities for prevention

  4. CKD – former definition • Irreversible, in most cases progresses slowly without visible symptoms until kidneys lose their ability of functioning • Leads to changes in volume and quality of fluids in human body, also causes an impairment of other organs and systems • It is diagnosed when persistently 3 months GFR value is < 90 ml/min

  5. CKD – new definition 1. Kidney damage for > 3 months with or without decreased GFR, as manifest by either: • Pathological abnormalities, or • Markers of kidney damage (composition of the blood, urine, imaging tests) 2. GFR < 90 ml/min/1,73 m2 for > 3 months with or without kidney damage

  6. CKD - etiology •Primary glomerulonephritis 23,75 % •Diabetic nephropathy 19,8 % •Interstitial nephritis 15,4 % (bacterial and non-bacterial) •Hypertonic Nephropathy 10,2 % •ADPKD 8 % •Systemic disaese 2,64 % •Amyloidosis (secondary) 1,85 % •Urinary tract neoplasms 1,19 % •Myeloma mult. 0,59 % •Gout 0,56 %

  7. Diabetes Hypertension 50.1% 27% Diabetes:The Most Common Cause of ESRD Primary Diagnosis for Patients Who Start Dialysis Glomerulonephritis Other No. of patients 10% 13% 700 Projection 95% CI 600 500 400 No. of dialysis patients (thousands) 520,240 300 281,355 200 243,524 100 r2=99.8% 0 1984 1988 1992 1996 2004 2000 2008 United States Renal Data System. Annual data report. 2000.

  8. CKD czy ARF- how to differentiate? • An interview- how long does it last? • Symptoms : -nocturia, polyuria, polydypsia -itching -sexual problems / irregular periods -bone pains, signs of secondary parathyroiditism • Tolerance of high urea and creatinine concentrations • Previously diagnosed renal impairment • Anaemia • Small kidneys in ultrasonography

  9. CKD – laboratory evaluation • Urea / creatinine serum concentration • Assessment of glomerular filtration – GFR -clearance methods -C-G formula -MDRD formula Cystatine C

  10. CKD-evaluation • creatinine - derives from muscles (phosphocreatine) - concentration dependent on body muscle mass i physical activity - production varies in the daytime- lower at night - excretion during glomerular filtration, it is not metabolized in kidney, 15% secretion in proximal tubule - according to the loss of kidney functioning this secretion increases (if GFR 40-80 ml/min, it is > 50%); and excretion of creatinine in bowels enhances (> 6 mg%) - tubular secretion is inhibited by Cimetidin, Trimetoprime, Amiloride

  11. CKD - evaluation • urea -end product in metabolism of aminoacids -concentration dependent on glomerular filtration and reabsorption in proximal tubule (due to sodium and water resorption) = 40% in excesive diuresis i 70% in heart failure and dehydration - dependent on protein intake, high catabolism, heamorrage from digestive tract, drugs, low sodium level, bilirubin level, liver failure

  12. Stages of CKD • I stage – kidney damage with normal or high GFR • GFR  90ml/min • proteinuria • II stage - kidney damage with mild decrease of GFR • GFR  89 i GFR > 60 ml/min • III stage – moderate decrease of GFR • GFR  59 i GFR > 30 ml/min • IV stage – severe decrease of GFR • GFR  29 i GFR  15 ml/min • V kidney failure • GFR <15 ml/min • dialysis

  13. Pcr -0% KF IV s. severe III s. moderate II s. mild I stage -100% GFR TIME – months? years?

  14. Pathogenesis • Number of nephrons decreases – a rise in concetration of waste from protein and purine metabolism, phosphate retention, acidosis, uremia toxins.

  15. Pathogenesis • Glomerular injury and injury of tubules always coexist in advanced stages of disease giving a reduce in filtration and an impairment of reabsorption – we have a lot of metabolic disturbances (impairment of excretory and regualtory function of kidney).

  16. Pathogenesis - CKD • Impaired endocrine function: • erythropoietin • 1,25- dihydroksy D3 • prostaglandins • natriuretic factor • kinins • Impaired metabolic function: • diminishion of gluconeogenesis • prolonged T 0,5 for insulin

  17. Hormonal disturbances • Secondary parathyreoiditism • Hiperinsulinaemia • Lack of erythropoietin • Lack of active vitamin D3 • Hiperprolactinaemia • Excess of endorfines • Enhanced secretion of somatothropine, calcitonine, gastrine, glukagon • Hipogonadism • Hiperleptynaemia • RAA system (renin-angiotensin-aldosterone) • ADH, natriuretic factors (BNP, ANP)

  18. Pcr -0% kidney injury mild CKD Dyslipidaemia Hypertension Impaired urine concentration -100% GFR Time- months? Years?

  19. II stage GFR 60 – 89 ml/min Often subclinical (may remain asymptomatic)! Prevalence of symptoms of primary kidney disease

  20. Stage II GFR 60 – 89 ml/min Impaired urine concentration  Isostenuria  Polyuria and nocturia Fluid accumulation hyponatremia Dehydration Fluid intake restriction, fever, vomitus, diarrhoea Heart failure Decrease in glomerular filtration

  21. Stage IIGFR 60 – 89 ml/min Arterial hypertension • possible in each kidney disease • frequency of occuring HA increases with progressive loss of glomerular filtration – stage II - 30 – 50% patients, stage V - 90% patients

  22. Stage IIGFR 60 – 89 ml/min Factors contributing to hypertension in kidney diseases • the type of renal disease • GFR value • sex • age • obesity • metabolic abnormalities of carbohydrates and lipids • excessive supplementation of sodium chloride

  23. Stage II GFR 60 – 89 ml/min Factors which take place in pathogenesis of HA in patients with impaired renal function • salt and water retention • inadequate activation of renin – angiotensin system • activation of symphatetic system • lack of vasodilatating factors • small activity of NO synthetase (ADMA) • circulating inhibitors of Na, K-ATPase • increase of calcium conc. in cells • increase of ET excretion • hyperleptinaemia

  24. Arterial Hypertension Renal impairment Progression of kidney failure depends on: • increase of HT (specifically systolic and pulse pressure) • lack of decrase of blood pressure at night (nondippers)

  25. DYSLIPIDAEMIA TG; CH(LDL) HDL CH (LDL); TG HDL CKD, HD Prot., Per.D, KTx

  26. Pcr -0% Renal impairment III stage moderate II stage mild Nutrition disturbances Abnormalities in Ca – Pi balance Anaemia Dyslipidaemia Arterial hypertension Impaired urine concentration -100% GFR Time-months? years?

  27. III stageGFR 30 – 59 ml/min Anaemia • appears, when glomerular filtration comes to 25 – 30 ml/min • 85 – 87% patients with GFR< 25 ml/min have Hb < 12 – 13 g/dl, but 25% patients with GFR> 60ml/min have Hb< 12 – 13 g/dl • 85% patients starting dialysis treatment have Hb< 10g/dl • normochromic, normocytic usually

  28. III stageGFR 30 – 59 ml/min Causes of anaemia • shorter time of erythrocytes life  uremic toxins  impaired resistance, deformities of cells  hipersplenism • chronic losses of blood • impairment in erythropoiesis  lack of erythropoietin production  iron deficit  advanced secondary parathyroiditism  coexisting inflammation  inefficient dose of dialysis • hemodilution

  29. Patophysiological consequences of anaemia • impaired transport and utilization of oxygen in tissues • heart hypertrophy • low exercise tolerance, weakness of muscles • deteriorating of CNS function • disturbances in immune system • hormonal disturbances

  30. Stage IIIGFR 30 – 59 ml/min Abnormalities in Ca-P metabolism • occur when GFR falls below 50 ml/min • can cause changes in bone structure – renal osteodystrophy • manifest as secondary pararthyreoiditism PTH is one of very important uremic toxins ! • are main factors of cardiovascular complications in kidney failure

  31. Renal Osteodystrophy • • osteitis fibrosa • • osteosklerosis • • osteomalacia • 2 forms of renal osteodystrophy • with high bone turnover • with low bone turnover

  32. Stage IIIGFR 30 – 59 ml/min Changes of nutrition • when GFR is about 50 ml/min patient spontaneusly starts to reduce protein and callories intake • metabolism of proteins changes • malnutrition gradually develops  loss of adipose tissue  loss of muscle mass  decrease in concentrations of protein, albumin, prealbumin, transferin

  33. Protein-Calorie Malnutrition • is an independent prognostic factor in patients with CKD • is one of the parts of MIA syndrome (Malnutrition, Inflammation, Atherosclerosis)

  34. Pcr -0% S.V S.IV severe Renal injury S.III moderate s. II mild Metabolic acidosis Changes in nutrition Disturbances of Ca – Pi balance Anaemia Dyslipidaemia Hypertension Impaired urine concentration -100% GFR Time – months? years?

  35. Stage IVGFR 15 – 29 ml/min Metabolic acidosis • is caused by low excretion of hydrogen ions • has varied impact on systems  enhances proteolysis and reduces protein synthesis (leads to malnutrition)  enhances resistance to insulin  changes metabolism of bones – impaires function of osteoblasts, enhances function of osteoclasts, enhances release of PTH  enhances production and release of 2-microglobulin  enhances hypertrigliceridaemia

  36. Stage IV GFR 15 – 29 ml/min • Signs – cardiovascular complications • Left ventricle hypertrophy 85% chorych • Left ventricle systolic insufficiency 16% chorych • Left ventricle concetric hypertrophy 41% chorych • Left ventricle distension 28% chorych • normal echocardiography 16% chorych • IHD (young without DM) 24% chorych • (aged with DM) 85% chorych • Arteriosclerosis obliterans in lower extremities (DM 1) 30% chorych • (DM 2) 40% chorych

  37. Stage IVGFR 15 – 29 ml/min Symptoms and signs • severe anaemia • bad controlled HA • overhydration • lack of appetite, nausea, vomitus, malnutrition • weakness, drowsiness • hyperkaliemia, hypocalcemia, hyperphosphatemia

  38. Kidney failure GFR < 15 ml/min SYSTEMIC SYMPTOMS AND SIGNS OF UREMIA + SYSTEMIC COMPLICATIONS OF KIDNEY FAILURE General symptoms • weakness, fatigue • insomnia • malnutrition, cachexia • changes in diuresis • dehydration, overhydration • itching

  39. Kidney failure GFR < 15 ml/min Cardiovascular system • HA • heart failure • IHD • arrhythmias and heart blocks • pericarditis Respiratory system • Kussmaul breathing • pleuritis • „uremic lung”

  40. Kidney failure GFR < 15 ml/min Gastrointerstinal tract • nausea, vomitus • anorexia • abdominal pain • gastroenteritis (inflammation of mucosa) • haemorrage from digestive tract Haematologic disorders • anaemia • thrombopathy • bleeding tendecy

  41. Kidney failure GFR < 15 ml/min Nervous s. • headache • peripheral neuropathy Psychical State • apathy • depression • deterioration of memory, thinking, association Motoric s. • pain in bones and joints • pathologic fractures • weakness of muscles, muscles atrophy

  42. Kidney failure GFR < 15 ml/min Genital s. • irregular menstruation • fertility • impotence • low libido Skin • dryness • pallor • scratches, excoriations • ecchymoses • mousy colour

More Related